• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      JB Chemicals enters into agreement with Taro Pharmaceutical industries

      Posted Atmyiris.com

      JB Chemicals (Q, N,C,F)* & Pharmaceuticals Ltd (JBCPL) has entered into a product development agreement with Taro Pharmaceutical Industries Ltd. (Nasdaq; TARO) and its affiliates and subsidiaries (`Taro` or the ``company`) Hawthorne, New York, USA, for the development of several products jointly for the US market.

      Today, the world sees the acceptance of India as a global hub for outsourcing of critical R&D services such as Product Development. The Company's consistent focus on Product Development has resulted in the development of rich captive research capabilities, knowledge and experience. The company plans to leverage these capabilities for any new product development to consolidate its position in the outsourcing of the global generic pharmaceutical industry.

      The company's strong and proven capabilities in R&D, state-of-the-art technology and a dedicated team of scientists, is expected to help it capitalize on Contract Research and Development opportunities. The company has been working on this business model for sometime and has shown its expertise in developing and manufacturing products for markets like USA, Australia, South Africa and Europe. The company plans to develop more products for the regulated markets and expects that these initiatives will provide a thrust to the future growth of the company.

      January 05, 2006


      Share this Article!

    Back to top^